CARDIOTROPIC PRESCRIPTION COMPOSITION

摘要

PURPOSE: To prepare a cardiotropic preparation having therapeutic effects for amending myocardiopathy systolic power, in spite of low toxicity, capable of heightening cardiovascular supplementary ability in well-known severe heart disease including cardiac insufficiency having an intractable reaction. CONSTITUTION: This a cardiotropic preparation containing cardiac glycoside and a-adrenaline receptor irritant contains nicotinamide adenine dinucleotide, cytochrome C and inosine (lipoxin) in the following mixing proportions (pts.wt.): cardiac glycoside: 0.05-0.2; a-adrenaline receptor irritant: 0.3-3.5; nicotinamide adenine dinucleotide: 0.5-5; cytochrome C: 5-15; inosine: 20-250.